首页 > 最新文献

Medizinische Klinik最新文献

英文 中文
[Systemic mastocytosis--definition of an internal disease]. 【系统性肥大细胞增多症——一种内部疾病的定义】。
Pub Date : 2010-08-01 Epub Date: 2010-09-08 DOI: 10.1007/s00063-010-1093-8
Jürgen Homann, Ulrich W Kolck, Andreas Ehnes, Thomas Frieling, Martin Raithel, Gerhard J Molderings

Systemic mastocytosis comprises disorders characterized by an accumulation of genetically altered mast cells in all organs and tissues due to an increased proliferation rate and reduced apoptosis of those pathologic mast cells. Release of their mediators can effectively influence organ function and can lead to systemic effects without inducing traces in routinely used laboratory parameters or imaging methods. In most cases, little invasive investigations allow diagnosing the disease and, hence, an appropriate therapy consisting of a basic medication with antihistamine and mast cell membrane-stabilizing compounds that should be supplemented, if required, by a medication adapted to individual symptoms, can be initiated. Because of the probably high prevalence of the disorder, systemic mastocytosis should be considered as a differential diagnosis in particular in the case of chronic gastrointestinal complaints such as abdominal pain/discomfort possibly associated with diarrhea, at an early stage.

全身性肥大细胞增多症包括以遗传改变的肥大细胞在所有器官和组织中积累为特征的疾病,这是由于这些病理性肥大细胞增殖率增加和凋亡减少所致。它们的介质的释放可以有效地影响器官功能,并可导致全身效应,而不会在常规使用的实验室参数或成像方法中引起痕迹。在大多数情况下,少量的侵入性检查可以诊断疾病,因此,可以开始适当的治疗,包括抗组胺药和肥大细胞膜稳定化合物的基本药物,如果需要,还可以补充适应个体症状的药物。由于这种疾病的患病率可能很高,系统性肥大细胞增多症应被视为一种鉴别诊断,特别是在早期出现慢性胃肠道疾病(如可能与腹泻相关的腹痛/不适)的情况下。
{"title":"[Systemic mastocytosis--definition of an internal disease].","authors":"Jürgen Homann,&nbsp;Ulrich W Kolck,&nbsp;Andreas Ehnes,&nbsp;Thomas Frieling,&nbsp;Martin Raithel,&nbsp;Gerhard J Molderings","doi":"10.1007/s00063-010-1093-8","DOIUrl":"https://doi.org/10.1007/s00063-010-1093-8","url":null,"abstract":"<p><p>Systemic mastocytosis comprises disorders characterized by an accumulation of genetically altered mast cells in all organs and tissues due to an increased proliferation rate and reduced apoptosis of those pathologic mast cells. Release of their mediators can effectively influence organ function and can lead to systemic effects without inducing traces in routinely used laboratory parameters or imaging methods. In most cases, little invasive investigations allow diagnosing the disease and, hence, an appropriate therapy consisting of a basic medication with antihistamine and mast cell membrane-stabilizing compounds that should be supplemented, if required, by a medication adapted to individual symptoms, can be initiated. Because of the probably high prevalence of the disorder, systemic mastocytosis should be considered as a differential diagnosis in particular in the case of chronic gastrointestinal complaints such as abdominal pain/discomfort possibly associated with diarrhea, at an early stage.</p>","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1093-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29291950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
[Is "evidence-based medicine" followed by "confidence-based medicine"?]. “循证医学”之后是“信心医学”吗?
Pub Date : 2010-08-01 Epub Date: 2010-09-08 DOI: 10.1007/s00063-010-1095-6
Franz Porzsolt, Heiner Fangerau

In an appeal concerning accusations of defamation, the England and Wales Court of Appeal Decisions determined that evidence-based statements are to be judged as opinions and not statements of fact. Since the authors consider it probable that this legal judgment will exert influence on physicians' decisions about the provision of health care services, they have compiled the implications of the judgment and discuss its consequences. The own analyses and considerations lead to the conclusion that confidence-based medicine follows evidence-based medicine. This extension is necessary because evidence-based medicine has not been able to generate the required trust. Therefore, it will be demanded to underpin the existing concept with additional data. These data will be necessary because it is no longer sufficient to convince scientists with data which are obtained under ideal conditions, but to convince critical members of society with additional data which have been obtained under everyday conditions.

在一项关于诽谤指控的上诉中,英格兰和威尔士上诉法院裁定,基于证据的陈述应被视为观点,而不是事实陈述。由于提交人认为这一法律判决很可能会影响医生关于提供保健服务的决定,因此他们汇编了这一判决的影响并讨论了其后果。通过自己的分析和考虑,得出基于信心的医学遵循循证医学的结论。这种扩展是必要的,因为循证医学尚未能够产生所需的信任。因此,需要用更多的数据来支持现有的概念。这些数据是必要的,因为用在理想条件下获得的数据来说服科学家已经不够了,而是要用在日常条件下获得的额外数据来说服社会的关键成员。
{"title":"[Is \"evidence-based medicine\" followed by \"confidence-based medicine\"?].","authors":"Franz Porzsolt,&nbsp;Heiner Fangerau","doi":"10.1007/s00063-010-1095-6","DOIUrl":"https://doi.org/10.1007/s00063-010-1095-6","url":null,"abstract":"<p><p>In an appeal concerning accusations of defamation, the England and Wales Court of Appeal Decisions determined that evidence-based statements are to be judged as opinions and not statements of fact. Since the authors consider it probable that this legal judgment will exert influence on physicians' decisions about the provision of health care services, they have compiled the implications of the judgment and discuss its consequences. The own analyses and considerations lead to the conclusion that confidence-based medicine follows evidence-based medicine. This extension is necessary because evidence-based medicine has not been able to generate the required trust. Therefore, it will be demanded to underpin the existing concept with additional data. These data will be necessary because it is no longer sufficient to convince scientists with data which are obtained under ideal conditions, but to convince critical members of society with additional data which have been obtained under everyday conditions.</p>","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1095-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29291952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Imaging of retroperitoneal fibrosis]. [腹膜后纤维化成像]。
Pub Date : 2010-08-01 DOI: 10.1007/s00063-010-1097-4
Lars Kamper, Alexander Sascha Brandt, Sven B Winkler, Hendrik Ekamp, Werner Piroth, Stephan Roth, Patrick Haage
{"title":"[Imaging of retroperitoneal fibrosis].","authors":"Lars Kamper,&nbsp;Alexander Sascha Brandt,&nbsp;Sven B Winkler,&nbsp;Hendrik Ekamp,&nbsp;Werner Piroth,&nbsp;Stephan Roth,&nbsp;Patrick Haage","doi":"10.1007/s00063-010-1097-4","DOIUrl":"https://doi.org/10.1007/s00063-010-1097-4","url":null,"abstract":"","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1097-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29291955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
[In-hospital resuscitation concept with first-responder defibrillation. 2-year experience]. 住院复苏概念与第一反应者除颤。2年经验)。
Pub Date : 2010-07-01 Epub Date: 2010-07-30 DOI: 10.1007/s00063-010-1080-0
Nils Robert, Cordula Kloppe, Andreas Mügge, Christoph Hanefeld

Background and purpose: Sudden cardiac arrest appears in 1-5 patients/ 1,000 clinical admissions. In spite of different research approaches, the prognosis after in-hospital resuscitation has not significantly improved in the last 40 years. This account presents the experiences with a hospital-wide emergency plan using the concept of defibrillation by first responders.

Methods: In 2003, a hospital-wide emergency plan was implemented. The concept comprised the setup of 15 "defibrillator points", training of the entire hospital personnel as first responder, and the introduction of an emergency team. Over the following 3 years, the concept was optimized. In a period from May 2006 to April 2008, the data of all patients who received an in-hospital resuscitation were collected.

Results: Within 24 months, a total of 41 resuscitations were conducted. Out of these, 24 patients (58%) were under intensive monitoring when the event occurred. Initially, 15 patients (36%) showed ventricular fibrillation, 15 (36%) a pulseless electrical activity, and eleven (27%) an asystoly. A total of twelve patients (29%) left hospital alive. About half of them (42%) experienced ventricular fibrillation and were under observation at the time of event.

Conclusion: The data collected since the implementation of the hospital- wide emergency plan in 2003 reflect the daily clinical routine. The results show that there is a better outcome especially in patients with ventricular fibrillation when receiving first-responder defibrillation.

背景和目的:心脏骤停发生率为1-5 / 1000。尽管采用了不同的研究方法,但在过去的40年里,住院复苏后的预后并没有显著改善。这篇文章介绍了医院范围内使用第一响应者除颤概念的应急计划的经验。方法:2003年实施全院应急预案。这一概念包括设立15个"除颤器点",培训整个医院的人员作为第一反应者,并建立一个紧急小组。在接下来的3年里,这个概念得到了优化。在2006年5月至2008年4月期间,收集了所有接受院内复苏的患者的数据。结果:24个月内共实施复苏41例。其中,24名患者(58%)在事件发生时接受了强化监测。最初,15例(36%)患者表现为心室颤动,15例(36%)无脉性电活动,11例(27%)心脏骤停。共有12名患者(29%)活着出院。其中约一半(42%)发生心室颤动,并在事件发生时接受观察。结论:2003年实施全院急诊计划以来收集的数据反映了日常临床常规。结果表明,特别是对心室颤动患者,接受第一反应性除颤治疗效果更好。
{"title":"[In-hospital resuscitation concept with first-responder defibrillation. 2-year experience].","authors":"Nils Robert,&nbsp;Cordula Kloppe,&nbsp;Andreas Mügge,&nbsp;Christoph Hanefeld","doi":"10.1007/s00063-010-1080-0","DOIUrl":"https://doi.org/10.1007/s00063-010-1080-0","url":null,"abstract":"<p><strong>Background and purpose: </strong>Sudden cardiac arrest appears in 1-5 patients/ 1,000 clinical admissions. In spite of different research approaches, the prognosis after in-hospital resuscitation has not significantly improved in the last 40 years. This account presents the experiences with a hospital-wide emergency plan using the concept of defibrillation by first responders.</p><p><strong>Methods: </strong>In 2003, a hospital-wide emergency plan was implemented. The concept comprised the setup of 15 \"defibrillator points\", training of the entire hospital personnel as first responder, and the introduction of an emergency team. Over the following 3 years, the concept was optimized. In a period from May 2006 to April 2008, the data of all patients who received an in-hospital resuscitation were collected.</p><p><strong>Results: </strong>Within 24 months, a total of 41 resuscitations were conducted. Out of these, 24 patients (58%) were under intensive monitoring when the event occurred. Initially, 15 patients (36%) showed ventricular fibrillation, 15 (36%) a pulseless electrical activity, and eleven (27%) an asystoly. A total of twelve patients (29%) left hospital alive. About half of them (42%) experienced ventricular fibrillation and were under observation at the time of event.</p><p><strong>Conclusion: </strong>The data collected since the implementation of the hospital- wide emergency plan in 2003 reflect the daily clinical routine. The results show that there is a better outcome especially in patients with ventricular fibrillation when receiving first-responder defibrillation.</p>","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1080-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29160249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Psychosomatic aspects of cardiac arrhythmias]. [心身方面的心律失常]。
Pub Date : 2010-07-01 Epub Date: 2010-07-30 DOI: 10.1007/s00063-010-1083-x
Martin Siepmann, Wilhelm Kirch

Emotional stress facilitates the occurrence of cardiac arrhythmias including sudden cardiac death. The prevalence of anxiety and depression is increased in cardiac patients as compared to the normal population. The risk of cardiovascular mortality is enhanced in patients suffering from depression. Comorbid anxiety disorders worsen the course of cardiac arrhythmias. Disturbance of neurocardiac regulation with predominance of the sympathetic tone is hypothesized to be causative for this. The emotional reaction to cardiac arrhythmias is differing to a large extent between individuals. Emotional stress may result from coping with treatment of cardiac arrhythmias. Emotional stress and cardiac arrhythmias may influence each other in the sense of a vicious circle. Somatoform cardiac arrhythmias are predominantly of psychogenic origin. Instrumental measures and frequent contacts between physicians and patients may facilitate disease chronification. The present review is dealing with the multifaceted relationships between cardiac arrhythmias and emotional stress. The underlying mechanisms and corresponding treatment modalities are discussed.

情绪紧张可促进心律失常的发生,包括心源性猝死。与正常人群相比,心脏病患者焦虑和抑郁的患病率有所增加。患有抑郁症的患者患心血管疾病死亡的风险增加。共病性焦虑症加重心律失常的病程。以交感神经张力为主的神经心脏调节紊乱被认为是导致这一现象的原因。对心律失常的情绪反应在很大程度上因人而异。应对心律失常的治疗可能会导致情绪紧张。情绪紧张和心律失常可能以一种恶性循环的方式相互影响。躯体型心律失常主要是心因性的。仪器测量和医患之间的频繁接触可能促进疾病的慢性化。目前的综述是处理心律失常和情绪应激之间的多方面的关系。并讨论了潜在的机制和相应的治疗方法。
{"title":"[Psychosomatic aspects of cardiac arrhythmias].","authors":"Martin Siepmann,&nbsp;Wilhelm Kirch","doi":"10.1007/s00063-010-1083-x","DOIUrl":"https://doi.org/10.1007/s00063-010-1083-x","url":null,"abstract":"<p><p>Emotional stress facilitates the occurrence of cardiac arrhythmias including sudden cardiac death. The prevalence of anxiety and depression is increased in cardiac patients as compared to the normal population. The risk of cardiovascular mortality is enhanced in patients suffering from depression. Comorbid anxiety disorders worsen the course of cardiac arrhythmias. Disturbance of neurocardiac regulation with predominance of the sympathetic tone is hypothesized to be causative for this. The emotional reaction to cardiac arrhythmias is differing to a large extent between individuals. Emotional stress may result from coping with treatment of cardiac arrhythmias. Emotional stress and cardiac arrhythmias may influence each other in the sense of a vicious circle. Somatoform cardiac arrhythmias are predominantly of psychogenic origin. Instrumental measures and frequent contacts between physicians and patients may facilitate disease chronification. The present review is dealing with the multifaceted relationships between cardiac arrhythmias and emotional stress. The underlying mechanisms and corresponding treatment modalities are discussed.</p>","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1083-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29160252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
[Pareses, myalgias, and massive CK elevation: a severe neurological disorder?]. 乏力、肌痛和大量CK升高:一种严重的神经系统疾病?
Pub Date : 2010-07-01 Epub Date: 2010-07-30 DOI: 10.1007/s00063-010-1084-9
Johannes Steinfurt, Markus C Müller, Anke Seidel, Richard Salm, Andreas Ochs

Case report: The authors report on a 51-year-old patient with transient pareses, myalgias, and a massive creatine kinase elevation which had led to an intensive neurological work-up by the general practitioner. Despite refractory hypertension, primary aldosteronism was not excluded. At the authors' clinic, the patient was diagnosed to have Conn's syndrome. Laparoscopic adrenalectomy revealed a big adenoma of the left adrenal gland.

Conclusion: Transient pareses, myalgias, and creatine kinase elevation can indicate primary aldosteronism among hypertensive patients. If clinically suspected, the aldosterone-renin ratio should be determined.

病例报告:作者报告了一名51岁的患者,患有短暂性麻痹,肌痛和大量肌酸激酶升高,导致全科医生进行了密集的神经系统检查。尽管难治性高血压,原发性醛固酮增多症不排除。在作者的诊所,病人被诊断出患有康氏综合症。腹腔镜肾上腺切除术发现左侧肾上腺有一个大的腺瘤。结论:高血压患者短暂性神经麻痹、肌痛和肌酸激酶升高可提示原发性醛固酮增多症。如临床怀疑,应测定醛固酮-肾素比值。
{"title":"[Pareses, myalgias, and massive CK elevation: a severe neurological disorder?].","authors":"Johannes Steinfurt,&nbsp;Markus C Müller,&nbsp;Anke Seidel,&nbsp;Richard Salm,&nbsp;Andreas Ochs","doi":"10.1007/s00063-010-1084-9","DOIUrl":"https://doi.org/10.1007/s00063-010-1084-9","url":null,"abstract":"<p><strong>Case report: </strong>The authors report on a 51-year-old patient with transient pareses, myalgias, and a massive creatine kinase elevation which had led to an intensive neurological work-up by the general practitioner. Despite refractory hypertension, primary aldosteronism was not excluded. At the authors' clinic, the patient was diagnosed to have Conn's syndrome. Laparoscopic adrenalectomy revealed a big adenoma of the left adrenal gland.</p><p><strong>Conclusion: </strong>Transient pareses, myalgias, and creatine kinase elevation can indicate primary aldosteronism among hypertensive patients. If clinically suspected, the aldosterone-renin ratio should be determined.</p>","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1084-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29160253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Targeted diagnosis of basilar artery thrombosis]. 【基底动脉血栓形成的针对性诊断】。
Pub Date : 2010-07-01 DOI: 10.1007/s00063-010-1085-8
Lars Kamper, Sven B Winkler, Hannes Meyn, Christian Scharwächter, Werner Piroth, Patrick Haage
{"title":"[Targeted diagnosis of basilar artery thrombosis].","authors":"Lars Kamper,&nbsp;Sven B Winkler,&nbsp;Hannes Meyn,&nbsp;Christian Scharwächter,&nbsp;Werner Piroth,&nbsp;Patrick Haage","doi":"10.1007/s00063-010-1085-8","DOIUrl":"https://doi.org/10.1007/s00063-010-1085-8","url":null,"abstract":"","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1085-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29160254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[New drugs for the treatment of constipation]. [治疗便秘的新药]。
Pub Date : 2010-07-01 Epub Date: 2010-07-30 DOI: 10.1007/s00063-010-1081-z
Birgit Adam, Tobias Liebregts, Guido Gerken

This review introduces new therapeutic options in the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. Therefore, prucalopride and lubiprostone are discussed including their mechanisms and side effects. In addition, other substances that are currently under evaluation such as renzapride and linaclotide are described, since recent results showed a significant effect in patients with constipation. Thus, after the withdrawal of tegaserod due to cardiac side effects, new potent drugs are now available for the treatment of constipation.

本文综述了治疗慢性特发性便秘和肠易激综合征伴便秘的新方法。因此,本文对普卡必利和鲁比前列酮的作用机制和副作用进行了讨论。此外,目前正在评估的其他物质,如伦沙必利和利那氯肽也被描述,因为最近的研究结果显示对便秘患者有显著效果。因此,在泰加塞罗德因心脏副作用而停药后,现在有新的强效药物可用于治疗便秘。
{"title":"[New drugs for the treatment of constipation].","authors":"Birgit Adam,&nbsp;Tobias Liebregts,&nbsp;Guido Gerken","doi":"10.1007/s00063-010-1081-z","DOIUrl":"https://doi.org/10.1007/s00063-010-1081-z","url":null,"abstract":"<p><p>This review introduces new therapeutic options in the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. Therefore, prucalopride and lubiprostone are discussed including their mechanisms and side effects. In addition, other substances that are currently under evaluation such as renzapride and linaclotide are described, since recent results showed a significant effect in patients with constipation. Thus, after the withdrawal of tegaserod due to cardiac side effects, new potent drugs are now available for the treatment of constipation.</p>","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1081-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29160250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Autoimmune thyroiditis (Hashimoto's thyroiditis): current diagnostics and therapy]. 自身免疫性甲状腺炎(桥本甲状腺炎):目前的诊断和治疗。
Pub Date : 2010-07-01 DOI: 10.1007/s00063-010-1082-y
Heike Fink, Gerhard Hintze

Hashimoto's thyroiditis is a common autoimmune thyroid disease with preference of female gender. The chronic thyroiditis is characterized by autoantibodies against thyroid peroxidase and thyroglobulin. With manifestation, there is often a subclinical hypothyroidism that finally progresses to a persistent hypothyroidism with typical clinical symptoms and the need of hormonal substitution in succession of the lymphocytic infiltration of the thyroid. The ultrasound of the thyroid shows a hypoechogenic and inhomogeneous parenchyma. Autoimmune thyroiditis is frequently associated with autoimmune disease of other organs, such as vitiligo, Addison's disease, diabetes mellitus type 1, often in the sense of polyglandular syndrome 2.

桥本甲状腺炎是一种常见的以女性为主的自身免疫性甲状腺疾病。慢性甲状腺炎的特点是有抗甲状腺过氧化物酶和甲状腺球蛋白的自身抗体。有症状时,常出现亚临床甲状腺功能减退,最终发展为持续的甲状腺功能减退,具有典型的临床症状,甲状腺淋巴细胞浸润后需要激素替代。甲状腺超声显示低回声不均匀的实质。自身免疫性甲状腺炎常与其他器官的自身免疫性疾病相关,如白癜风、阿狄森氏病、1型糖尿病,常伴有多腺综合征2。
{"title":"[Autoimmune thyroiditis (Hashimoto's thyroiditis): current diagnostics and therapy].","authors":"Heike Fink,&nbsp;Gerhard Hintze","doi":"10.1007/s00063-010-1082-y","DOIUrl":"https://doi.org/10.1007/s00063-010-1082-y","url":null,"abstract":"<p><p>Hashimoto's thyroiditis is a common autoimmune thyroid disease with preference of female gender. The chronic thyroiditis is characterized by autoantibodies against thyroid peroxidase and thyroglobulin. With manifestation, there is often a subclinical hypothyroidism that finally progresses to a persistent hypothyroidism with typical clinical symptoms and the need of hormonal substitution in succession of the lymphocytic infiltration of the thyroid. The ultrasound of the thyroid shows a hypoechogenic and inhomogeneous parenchyma. Autoimmune thyroiditis is frequently associated with autoimmune disease of other organs, such as vitiligo, Addison's disease, diabetes mellitus type 1, often in the sense of polyglandular syndrome 2.</p>","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1082-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29160251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
[Symptomatic pericardial cyst]. [症状性心包囊肿]。
Pub Date : 2010-06-01 DOI: 10.1007/s00063-010-1075-x
Oliver Rasp, Christian Paetzel, Walter Eichinger, Robert H G Schwinger
{"title":"[Symptomatic pericardial cyst].","authors":"Oliver Rasp,&nbsp;Christian Paetzel,&nbsp;Walter Eichinger,&nbsp;Robert H G Schwinger","doi":"10.1007/s00063-010-1075-x","DOIUrl":"https://doi.org/10.1007/s00063-010-1075-x","url":null,"abstract":"","PeriodicalId":18420,"journal":{"name":"Medizinische Klinik","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00063-010-1075-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29085093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medizinische Klinik
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1